Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms 225Ac-DOTATATE, 225Ac-RYZ-101, RYZ 101 + [1] |
Target |
Action antagonists |
Mechanism SSTR2 antagonists(Somatostatin receptor 2 antagonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Carcinoid Tumor | Phase 3 | United States | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | Belgium | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | Brazil | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | Canada | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | France | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | Netherlands | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | South Korea | 24 Mar 2022 | |
Carcinoid Tumor | Phase 3 | Spain | 24 Mar 2022 | |
Functioning Endocrine Neoplasm | Phase 3 | United States | 24 Mar 2022 | |
Functioning Endocrine Neoplasm | Phase 3 | Belgium | 24 Mar 2022 |
Phase 1 | 17 | vpuqssdnfo(nwcxkqubdf) = There was one grade 5 TEAE of hepatic failure that was deemed unrelated to the study drug ltmonsshcf (pkdbppicax ) View more | Positive | 23 Jan 2025 | |||
NCT05595460 (WCLC2024) Manual | Phase 1 | 10 | abnfuxwiml(udguhmdweh) = G1 decreased appetite, G2 dehydration, G1 diarrhea, G1 fatigue, G2 influenza-like illness, G2 nausea, G2 neutrophil count decrease, G1 vomiting jyngdrqrvc (wwenvwtmwa ) View more | Positive | 08 Sep 2024 | ||
Phase 3 | - | RYZ101 120 kBq/kg | svfrcjueha(tmttadjwvk) = 52.9% tqvpxsxayp (jfqecjqaay ) View more | - | 09 Jun 2024 | ||
Phase 1 | 17 | RYZ101 120 kBq/kg | jbcvbdesea(gfkmcedoem) = dnnoiavyno brpfvbyurn (iaqyegwbhc ) View more | Positive | 24 May 2024 | ||
Phase 1 | Gastro-Enteropancreatic Neuroendocrine Tumor SSTR positive | 17 | occrgkrngx(bpeyzsicue) = xvsingcerc bnxudobfih (zqsxpncwoa ) View more | Positive | 22 Oct 2023 | ||
Phase 1 | SSTR2 positive Gastro-Enteropancreatic Neuroendocrine Tumor SSTR2 Expression | 9 | qzabodolmo(vastgmeydg) = afejhcbubc kmrrdduhsv (kculcgabkp ) View more | Positive | 31 May 2023 | ||
Not Applicable | - | uspvpbosrn(uyzwajbjec) = Malignant ascites was noted in 14, resulting in 11 deaths jixfpqobbb (fgyxobggek ) View more | - | 08 Aug 2022 | |||
Not Applicable | - | imejrkyrwh(dkilbtumug) = No grade 3 renal or hepatotoxicities were observed. No other unexpected longer-term adverse events were observed with 225Ac-DOTATATE therapy saqwlecawi (ofelmpekwz ) View more | - | 18 May 2021 |